Search research articles
Contact Us
Filters
Showing results (1241-1250 of 1,518) with videos related to
Page
of 152
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 29, 2016
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
Silvia Novello, Giorgio Scagliotti, Gilberto de Castro, et al.
Journal of Pediatric Surgery
|
May 19, 2018
A structured bowel management program for patients with severe functional constipation can help decrease emergency department visits, hospital admissions, and healthcare costs
Carlos A Reck-Burneo, Alejandra Vilanova-Sanchez, Alessandra C Gasior, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
The molecular architecture of tunneling nanotubes
Eva P Karasmanis, Siyu Chen, Farhaz Shaikh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 17, 2016
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
Martin Reck, Mark A Socinski, Alexander Luft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2023
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
E Felip, N Altorki, C Zhou, et al.
Journal of Medicinal Chemistry
|
July 12, 2012
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile
Folkert Reck, Richard A Alm, Patrick Brassil, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
British Journal of Cancer
|
May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC
Dörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 3, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
M Früh, C M Panje, M Reck, et al.
Acta Psychiatrica Scandinavica
|
August 22, 2009
Perceived parental rearing in subjects with obsessive-compulsive disorder and their siblings
L Lennertz, H J Grabe, S Ruhrmann, et al.
Page
of 152
Search research articles
Search
Showing results (1241-1250 of 1,518) with videos related to
Sort By:
Page
of 152
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 29, 2016
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer
Silvia Novello, Giorgio Scagliotti, Gilberto de Castro, et al.
Journal of Pediatric Surgery
|
May 19, 2018
A structured bowel management program for patients with severe functional constipation can help decrease emergency department visits, hospital admissions, and healthcare costs
Carlos A Reck-Burneo, Alejandra Vilanova-Sanchez, Alessandra C Gasior, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
The molecular architecture of tunneling nanotubes
Eva P Karasmanis, Siyu Chen, Farhaz Shaikh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 17, 2016
The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial
Martin Reck, Mark A Socinski, Alexander Luft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 19, 2023
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
E Felip, N Altorki, C Zhou, et al.
Journal of Medicinal Chemistry
|
July 12, 2012
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile
Folkert Reck, Richard A Alm, Patrick Brassil, et al.
Science Advances
|
June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2
Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
British Journal of Cancer
|
May 3, 2025
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC
Dörte Nitschkowski, Tim Vierbuchen, Holger Heine, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 3, 2020
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
M Früh, C M Panje, M Reck, et al.
Acta Psychiatrica Scandinavica
|
August 22, 2009
Perceived parental rearing in subjects with obsessive-compulsive disorder and their siblings
L Lennertz, H J Grabe, S Ruhrmann, et al.
Page
of 152